Rappel de produit Vita Health Ibuprofène (2021-10-01)
- Date de début :
- 1 octobre 2021
- Type de communication :
- Retrait de marché d'une drogue
- Sous-catégorie :
- Médicaments
- Classification du risque :
- Type III
- Source :
- Santé Canada
- Problème :
- Sécurité des produits
- Public :
- Grand public, Professionnels de la santé, Hôpitaux
- Numéro d’identification :
- RA-76635
Dernière mise à jour:
2021-10-19
Résumé
-
Produit:
A. Ibuprofen Tablets 200mgB. Ibuprofen Caplets 200mg
A. Ibuprofen Tablets 200mg
B. Ibuprofen Caplets 200mg
Raison
Une impureté est hors spécifications dans les lots concernés.
Étendue de la distribution
Grossistes
Produits touchés
Régulier Comprimés d'Ibuprofène 200mg
DIN, NPN, DIN-HM
DIN 02368072
Forme posologique
Comprimé
Concentration
Ibuprofène 200mg
Numéro de lot ou de série
Neuveaux lots rappelés: 0C42051PF,0C42051PE,0C42051PF , 0G25553UY,0G25553UE,0G25553UX,0G25553UG,0G25553UH, 0G25553UV,0G25653ZX,0G25654PJ,0G25653UY ,0G25654PP,0G25654P9,0G25653UW,0G25653UB,0G25653UM,0G25654PS,0G25654NW,0G25653UP,0G25653UL,0G25654NA,0G26053UK,0G26053UR,0G26055B4,0G26054PN,0G26054NA,0J3305608,0J33055CB,0J3305609,0J33057V7,0J33054PN,0J3305625,0J3305628,0J3305624,0J33054N8,0J330562A,0J3305629,0J330B56WE,0J330B58GF,1B1B24857VC,248570G, 1B248570C,1B24857V7,1B248570F,1B24857VB,1B24857VE,1B24857VG,1B24857V9,1B2485627,1B24857V8,1B24857VK,1B24857V5,1B24857VH,1B24957V6,1B24957VF,1B24957VC,1B2495626,1B24957V4,1B24957VJ,1B24957VL,1B24957V5,1B249B58GF,1B249B,1C20858CC,1C20858CE,1C20858CF,1C20858CG,1C20858CM,1C20858C9,1C20858CN,1C20858CP,1C20858CQ,1C20858CK,1C20858CL,1C20858CH,1C20858CJ,1C20858CA,1C2085951,1C20858CT,1C20858CR,1C20858CS,1C20858CB,1F19459UL,1F19459UY,1F19459UW,1F19459UZ,1F19459UX,1F19459UV,1F19459UR,1F19459UF,1F19459UQ,1F19558QU,1F19559UX,1F19559UC,1F19559UU,1F19559UN,1F19559U9,1F19559UA,1F19559UM,1F19559UG,1F19559UJ,1F19559UT,1F19559UK,1F19559UQ,1F19559UH,1F19559US,1F19559UB,1F19658QU,1F1965A7S,1F1965A7Q,1F1965A7R,1F1965A30,1F196B5A56,1F196B,1F1975BLC,1F1975A7U,1F1975A7V,1F1975A7W,1F1975ALH,1F1975A7Z,1F1975A7X,1F1975A7Y,1F1975ALG,1F1975ALJ,1F1975ALK,1F1975A80,1F1975A81,9F2514V8W,9F2524V98,9F2524V8U,9F2524V96,9F2524V9A,9F2524V8Y,9F2524V8S,9F2524V8W,9F2534V99,9F2534V8N,9F2534V8L,9F2534V8Q,9F2534V8P,9F2534V8M,9F2534VK6,9F2534V8T,9F2534VF3,9F2534V9A,9F2534VES,9F2534VET,9F2534V97,9F2534V8R,9F2824V94,9F2824V8X,9F2824V8V,9F2824V95,9F2824V9W,9F2824V97,9F2834V92,9F2834W2E,9F2834VCV,9F2834V94,9F2834V8X,9F2834V91,9F2834V90,9F2834VN2,9F2834V8V,9F2834VTW,9F2834VRT,9F2834VRS,9F2834VXX,9F2834VRV,9F2834W3P,9F2834W3G
Entreprises
- Firme effectuant le retrait
-
Vita Health Products Inc.
150, ave. Beghin,
Winnipeg
R2J 3W2
Manitoba
CANADA
- Détenteur d'autorisation de mise en marché
-
Vita Health Products Inc.
150, avenue Beghin
Winnipeg
R2J 3W2
Manitoba
CANADA
Caplets d'ibuprofène 200mg
DIN, NPN, DIN-HM
DIN 02368080
Forme posologique
Caplet
Concentration
Ibuprofène 200mg
Numéro de lot ou de série
Nouveaux lots rappelés: 0C42151S0,0C42151PK,0C42151PL,0C42151S5,0C42151S6,0C42151S9,0C42151S7,0C42151S8,0C42151S1,0C42151RY,0C42151RZ,0C42151SE,0C42151S3,0C42151S4,0C42151PJ,0C42151SG,0C42151SH,0C42151SF,0C42251S0,0C42251SJ,0C42251SA,0C42251SB,0C42251S2,0C42252EM,0C42351ZY,0C42352EM,0C42451ZY,0J26754A8,0J26855NE,0J26855NC,0J26855KR,0J268562T,0J26854A8,0J27156U0,0J27156PP,0J27156PV,0J27156PM,0J27156PN,0J27156PR,0J27156PS,0J27154NN,0J271562T,0J27154QG,0J2715655,0J27256PT,0J27256PN,0J27256PL,0J27256R2,0J27356R2,0K38556PL,0K38557F3,0K38556R2,0K38556R3,0K38656R3,0K38756R3,1B2555807,1B2555809,1B25558GS,1B255580F,1B255580G,1B255580H,1B2555808,1B25558L3,1B255580C,1B255580E,1B255580A,1B255580B,1B25558LB,1B255580J,1B25658L4,1B25658KT,1B25658LF,1B25658LK,1B25658LP,1B25658LL,1B25658LM,1B25658LN,1B25658L8,1B25658L9,1B25658L3,1B256591U,1B256591V,1B25658LH,1B25658LJ,1B25658LG,1B25658LC,1B256592J,1B25658LR,1B25658LS,1B25658LQ,1B25759A4,1B2575980,1B2575983,1B2575993,1B2575994,1B2575999,1B25759AC,1B257599C,1B25759AB,1B257599A,1B25759A5,1B25759A6,1B257591T,1B25759AA,1B257594Q,1B25759A8,1B257592J,1B257597G,1B25859AE,1B25859P0,1B2585980,1B25859E2,1B25859E3,1B25859P5,1B25859A7,1B25859A9,1B25959A7,9F2484V9U,9F2484V6Z,9F2484VBU,9F2484V68,9F2494VEX,9F2494V78,9F2494V67,9F2494V7A,9F2494V77,9F2494VBU,9F2494V71,9F2504V71,9F2504V6C,9F2504VEX,9F2504V72,9F2504V73,9F2504V70,9F2504V9S,9F2504V7E,9F2504V75,9F2504V6X,9F2504V9T,9F2504V4G,9F2504V66,9F2504V79,9F2504V9V,9F2504VE7,9F2504V74,9F2504V6E,9F2504V71,9F2504V68,9F2844VN1,9F2844WBC,9F2844W42,9F2844V64,9F2844W5F,9F2844VNW,9F2844W5J,9F2844V7C,9F2844W7A,9F2844W79,9F2844V7A,9F2844VXY,9F2844VXZ,9F2844W3B,9F2844W72,9G3304WEL,9G3304WC3,9G3304X8F,9G3304WWB,9G3304WWH,9G3304WEP,9G3304WTP,9G3304XF1,9G3304WER,9G3304WEQ,9G3304XJ4,9G3304WEJ,9G3304WEM,9G3304XEB,9G3304WL9,9G3304WEH,9G3304WEK,9G3304WWC,9G3304WEF,9G3304WWF
Entreprises
- Firme effectuant le retrait
-
Vita Health Products Inc.
150, avenue Beghin
Winnipeg
R2J 3W2
Manitoba
CANADA
- Détenteur d'autorisation de mise en marché
-
Vita Health Products Inc.
150, avenue Beghin
Winnipeg
R2J 3W2
Manitoba
CANADA